Author(s):
Pavankumar Krosuri, K.Ravikumar, S.N.Priyanka, G.Anjana Devi, S.Lakshmiprasanna, A.Sujatha, A.Akhila
Email(s):
pavankumarmph@gmail.com
DOI:
10.52711/0974-360X.2021.01035 
Address:
Pavankumar Krosuri*, K.Ravikumar, S.N.Priyanka, G.Anjana Devi, S.Lakshmiprasanna, A.Sujatha, A.Akhila
Department of Pharmaceutics.Santhiram College of Pharmacy, Nandyal, Andhrapradesh, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 11,
Year - 2021
ABSTRACT:
Diloxanide Furoate is a Dichloroacetamide derivative utilized for the treatment of various protozoal infections like amoebiasis. Colon targeted tablets were designed using pH sensitive polymers like Eudragit S100, Eudragit L 100,Cellulose acetate phthallate at different concentrations. All the matrix,compression coated formulations showed the desired physicochemical properties as per the official limits. The drug release studies were performed according to the USP paddle method by using 0.1N HCL for 2 hours, pH 7.4 phosphate buffer for 3 hours and pH 6.8 phosphate buffer upto 18 hours. A better controlled drug release was shown for Eudragit L 100. Based on the comparative drug release studies among different Formulations F9 with Eudragit L 100 polymer showed better control drug release. The release kinetics for the Optimised Formulation F9 was calculated and “r2” value was more for Zero order kinetics i.e.,0.970 indicating that the formulation doesnot depend upon its concentration and from the Korsmeyer peppas model the diffusion exponent value “n” is > 1 indicating that it follows super case II transport mechanism. The accelerated stability studies conducted for optimised formulation F9 for 3 months have no significant variation.
Cite this article:
Pavankumar Krosuri, K.Ravikumar, S.N.Priyanka, G.Anjana Devi, S.Lakshmiprasanna, A.Sujatha, A.Akhila. Formulation and Evaluation of colon targeted drug Delivery of Diloxanide furoate Tablets using pH Dependent Polymers. Research Journal of Pharmacy and Technology. 2021; 14(11):5959-4. doi: 10.52711/0974-360X.2021.01035
Cite(Electronic):
Pavankumar Krosuri, K.Ravikumar, S.N.Priyanka, G.Anjana Devi, S.Lakshmiprasanna, A.Sujatha, A.Akhila. Formulation and Evaluation of colon targeted drug Delivery of Diloxanide furoate Tablets using pH Dependent Polymers. Research Journal of Pharmacy and Technology. 2021; 14(11):5959-4. doi: 10.52711/0974-360X.2021.01035 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-11-61
REFERENCES:
1. Eptissam Younan Pirko, Wafaa Fadhil Hamad, Nihad KhalaweTektook. Estimation levels of Immunoglobulin and Complement in Amoebiasis patients (Amebic Dysentery). Research J. Pharm. and Tech. 2019; 12(7):3555-3558.
2. 2.Naikwada SR, Kulkarni PP, Jathar SR and Bajaj AN, “Development of time and pH dependent Controlled release colon specific delivery of tinidazole” DARU.J.pharm.sci.2008,16(3),119-127.
3. Craig CR,Stitzel RE and Scheibel LW , Modern pharmacology with clinical applications: antiprotozol Drugs ,5thEdn ,little Brown publisher, 1994,PP606-620.
4. Tripathi KD,Essential of pharmacology ,6th Edn, Jaypee publication, New delhi,2006 ,pp 797-807.
5. Faust DM and Guillen N, “Virulence and Virulence factors in Entamoeba histolytica , the agents of human amoebiasis.”micro.infec.2012,14,1428-1441.
6. Haslett C, Chilvers ER Boon NA,Colledge NR and Hunter JA, Davidsons Principles and practice of medicine, 19thEdn , Churcill Livingstone, Elsevier Science limited ,2002,45-46.
7. Swarbrick,Lee VHL and Mukherjee SK ,Encyclopedia of pharmaceutical Technology:Drug Delivery: Oral Colon- Specific, 3rdEdn,informa health care,Newyork,London,2007,1,pp 1228-1241.
8. Kumar P and Mishra B, “colon targeted drug delivery systems.” Curr.drug deli2008, 5, 186-198.
9. Wen H, Park K , milabuer MN, Kam Y, and Rubinstein A Oral controlled Release Formulation Design and Drug Delivery- Theory to practice, John wiley& Sons, inc ,Hoboken , new Jersey, 2010,pp 225-244.
10. Wilson CG and Rathbone MJ , Modified- Release Drug Delivery Technology,edited and Published by Marcel Dekker , 2002, pp 217-222.
11. Vyas SP and Khar RK , Targeted and controlled Drug Delivery , 1st Edn , CBS publisher and distributor , New Delhi, 2002,pp218 256.
12. Singh G Kumar D, Singh M, Sharma D and Kaur S, “Emerging Techniques and challengs in Colon Drug Delivery Systems.” J. app . pharm. Sci. 2012, 3, 139- 147.
13. Jain NK and Subramanyam C, Advances in controlled and novel Drug Dlivery, 1st Edn,CBS publisher and Distributor, New Delhi, pp89-119.
14. Chourasia Mk and Jain SK “ Pharmaceutical approaches to colon targeted Drug delivery system .” j. pharm. Sci. 2003, 33-66.
15. Aulton ME. Pharmaceutics: the Science of Dosage Form Design, 2nd edition published by Livingstone C. Elsevier Science Ltd. 2002; 289-315.arcel Dekker, Inc: New York, 2005, 29, pp 4, 5,296.
16. Vinay Kumar KV , Shiva Kumar T and Tamizh mani T , “ colon Targeting drug delivery system: A review on recent approaches” lnt.j. pharm. Biomed. Sci. 2011, 2(1), 11-19.